The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Protein tyrosine phosphatases as potential therapeutic targets
Open accessAbstract
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human diseases, such as cancers, diabetes, autoimmune disorders, and neurological diseases. Indeed, protein tyrosine phosphorylation-mediated signaling events offer ample therapeutic targets, and drug discovery efforts to date have brought over two dozen kinase inhibitors to the clinic. Accordingly, protein tyrosine phosphatases (PTPs) are considered next-generation drug targets. For instance, PTP1B is a well-known targets of type 2 diabetes and obesity, and recent studies indicate that it is also a promising target for breast cancer. SHP2 is a bona-fide oncoprotein, mutations of which cause juvenile myelomonocytic leukemia, acute myeloid leukemia, and solid tumors. In addition, LYP is strongly associated with type 1 diabetes and many other autoimmune diseases. This review summarizes recent findings on several highly recognized PTP family drug targets, including PTP1B, Src homology phosphotyrosyl phosphatase 2(SHP2), lymphoid-specific tyrosine phosphatase (LYP), CD45, Fas associated phosphatase-1 (FAP-1), striatal enriched tyrosine phosphatases (STEP), mitogen-activated protein kinase/dual-specificity phosphatase 1 (MKP-1), phosphatases of regenerating liver-1 (PRL), low molecular weight PTPs (LMWPTP), and CDC25. Given that there are over 100 family members, we hope this review will serve as a road map for innovative drug discovery targeting PTPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–253 of 253
Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases
Jarvis, L. A., Peters, S. T., Simon, M. A., Krasnow, M. A., & Smith-Bolton, R. K. (2006) · Development · doi:10.1242/dev.02255 · Cited by 72
Distinct gating modes determine the biphasic relaxation of NMDA receptor currents
Zhang, W., Howe, J. R., & Popescu, G. (2008) · Nature Neuroscience · doi:10.1038/nn.2214 · Cited by 72
Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice
Yao, Y., Slosberg, E. D., Wang, L., Hibshoosh, H. H., Zhang, Y., Xing, W.-Q., Santella, R. M., & Weinstein, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202908 · Cited by 71
Bult, A., Zhao, F., Dirkx, R. A., Raghunathan, A., Solimena, M., & Lombroso, P. J. (1997) · PubMed · Cited by 71
Gregorieff, A., Cloutier, J., & Veillette, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13217 · Cited by 69
Expression and Potential Role of Fas-Associated Phosphatase-1 in Ovarian Cancer
Meinhold-Heerlein, I. M., Stenner, F., Liewen, H., Kitada, S., Krajewska, M., Krajewski, S., Zapata, J. M., Monks, A. P., Scudiero, D. A., Bauknecht, T., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64084-9 · Cited by 69
Wu, J. J., Zhang, L., & Bennett, A. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4792-4803.2005 · Cited by 69
Srikanth, S., Franklin, C. C., Duke, R. C., & Kraft, A. S. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006980326855 · Cited by 68
He, Y., Liu, S., Menon, A., Stanford, S. M., Oppong, E. K., Gunawan, A. M., Wu, L., Wu, D. J., Barrios, A. M., Bottini, N., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400248c · Cited by 67
Self-citationPTPL1: a large phosphatase with a split personality
Abaan, O. D., & Toretsky, J. A. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9114-2 · Cited by 66
Katagiri, T., Ogimoto, M., Hasegawa, K., Arimura, Y., Mitomo, K., Okada, M., Clark, M. R., Mizuno, K., & Yakura, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1321 · Cited by 65
Dromard, M., Bompard, G., Glondu-Lassis, M., Puech, C., Chalbos, D., & Freiss, G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0513 · Cited by 63
Mkp1Is a c-Jun Target Gene That Antagonizes JNK-Dependent Apoptosis in Sympathetic Neurons
Kristiansen, M., Hughes, R., Patel, P., Jacques, T. S., Clark, A. R., & Ham, J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2824-10.2010 · Cited by 62
Rojo, F., González-Navarrete, I., Bragado, R., Dalmases, A., Menéndez, S., Cortés-Sempere, M., Suárez, C., Oliva, C., Servitja, S., Rodríguez‐Fanjul, V., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2070 · Cited by 62
Yeh, S., Wu, D.-C., Tsai, C.-Y., Kuo, T.-J., Yu, W.-C., Chang, Y.-S., Chen, C., Chang, C.-F., Chen, D., & Chen, P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1383 · Cited by 61
Stanford, S. M., Krishnamurthy, D., Falk, M. D., Messina, R., Debnath, B., Li, S., Liu, T., Kazemi, R., Dahl, R., He, Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101202j · Cited by 59
Self-citationPRL2/PTP4A2 Phosphatase Is Important for Hematopoietic Stem Cell Self-Renewal
Kobayashi, M., Bai, Y., Dong, Y., Yu, H., Chen, S., Gao, R., Zhang, L., Yöder, M. C., Kapur, R., Zhang, Z., et al. (2014) · Stem Cells · doi:10.1002/stem.1672 · Cited by 59
Self-citationPagel, J. M., Kenoyer, A. L., Bäck, T. A., Hamlin, D. K., Wilbur, D. S., Fisher, D. R., Park, S. I., Frayo, S. L., Axtman, A., Orgun, N. N., et al. (2011) · Blood · doi:10.1182/blood-2011-04-347039 · Cited by 59
Mali, R. S., Ma, P., Zeng, L., Martin, H., Ramdas, B., He, Y., Sims, E. K., Nabinger, S. C., Ghosh, J., Sharma, N., et al. (2012) · Blood · doi:10.1182/blood-2011-08-375873 · Cited by 57
Self-citationRamponi, G., & Stefani, M. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00109-4 · Cited by 57
Mitogen-activated protein kinases and apoptosis in PIN
Magi‐Galluzzi, C., Montironi, R., Cangi, M. G., Wishnow, K., & Loda, M. F. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050184 · Cited by 56
Dong, Y., Zhang, L., Zhang, S., Bai, Y., Chen, H., Sun, X., Yong, W., Li, W., Colvin, S. C., Rhodes, S. J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393462 · Cited by 56
Self-citationIrreversible kinase inhibitors gain traction
Sanderson, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4103 · Cited by 55
Bompard, G., Martin, M., Roy, C., Vignon, F., & Freiss, G. (2003) · Journal of Cell Science · doi:10.1242/jcs.00448 · Cited by 55
MAEKAWA, K., Imagawa, N., Naito, A., Harada, S., Yoshie, O., & TAKAGI, S. (1999) · Biochemical Journal · doi:10.1042/bj3370179 · Cited by 54
Selective Regulation of Lyn Tyrosine Kinase by CD45 in Immature B Cells
Katagiri, T., Ogimoto, M., Hasegawa, K., Mizuno, K., & Yakura, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.27987 · Cited by 51
Rigacci, S., Rovida, E., Sbarba, P. D., & Berti, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201709200 · Cited by 51
Saras, J., Engström, U., Góñez, L. J., & Heldin, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20979 · Cited by 49
New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53
Min, S.-H., Deuk‐Su, K. I. M., Heo, Y.-S., Kim, Y., Kim, H., Kim, J., Han, Y.-M., Kim, I.-C., & Yoo, O.-J. (2008) · Oncogene · doi:10.1038/onc.2008.409 · Cited by 48
Phosphatase of regenerating liver: a novel target for cancer therapy
Campbell, A. M., & Zhang, Z. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.892926 · Cited by 48
Self-citationTargeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11 -Associated Malignancies
Yu, B., Liu, W., Yu, W., Loh, M. L., Alter, S. P., Guvench, O., MacKerell, A. D., Li-da, T., & Qu, C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0049-t · Cited by 48
Phosphatase of Regenerating Liver 2 (PRL2) Deficiency Impairs Kit Signaling and Spermatogenesis
Dong, Y., Zhang, L., Bai, Y., Zhou, H., Campbell, A. M., Chen, H., Yong, W., Zhang, W., Zeng, Q., Shou, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512079 · Cited by 45
Self-citationThe p38α mitogen-activated protein kinase as a central nervous system drug discovery target
Borders, A. S., de Almeida, L., Eldik, L. J. V., & Watterson, D. M. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s12 · Cited by 45
Crystal Structure of the PTPL1/FAP-1 Human Tyrosine Phosphatase Mutated in Colorectal Cancer
Villa, F., Deák, M., Bloomberg, G. B., Alessi, D. R., & van Aalten, D. M. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412211200 · Cited by 43
Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity
Wansink, D. G., Peters, W., Schaafsma, I., Sutmuller, R. P. M., Oerlemans, F. T. J. J., Adema, G. J., Wieringa, B., der Zee, C. E. E. M. V., & Hendriks, W. J. A. J. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00079.2004 · Cited by 43
Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2
Min, S., Kim, D., Heo, Y.-S., Kim, H. M., Kim, I., & Yoo, O.-J. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.11.010 · Cited by 42
Autocatalytic Phosphorylation of CDK2 at the Activating Thr160
Abbas, T., Jha, S., Sherman, N. E., & Dutta, A. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4000 · Cited by 41
Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival
Yang, Z., Li, Y., Yin, F., & Chan, R. J. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.04.016 · Cited by 41
Ballerini, C., Rosati, E., Salvetti, M., Ristori, G., Cannoni, S., Biagioli, T., Massacesi, L., Sorbi, S., & Vergelli, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00565-7 · Cited by 38
Walls, C. D., Iliuk, A. B., Bai, Y., Wang, M., Tao, W. A., & Zhang, Z. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.028886 · Cited by 38
Self-citationJacobsen, M., Hoffmann, S., Cepok, S., Stei, S., Ziegler, A., Sommer, N., & Hemmer, B. (2002) · Immunogenetics · doi:10.1007/s00251-002-0455-7 · Cited by 37
Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors
He, Y., Zeng, L., Yu, Z.-H., He, R., Liu, S., & Zhang, Z. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.004 · Cited by 35
Self-citationWieckowski, E. U., Atarashi, Y., Stanson, J., Sato, T., & Whiteside, T. L. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20922 · Cited by 34
Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma
Xu, J., Zeng, L., Shen, W., Turchi, J. J., & Zhang, Z. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.028 · Cited by 34
Self-citationStanton, T., Boxall, S., Hirai, K., Dawes, R., Tonks, S., Yasui, T., Kanaoka, Y., Yuldasheva, N. Y., Ishiko, O., Bodmer, W. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931490100 · Cited by 33
Fine-tuning MAPK signalling in the brain
Jeanneteau, F. D., & Deinhardt, K. (2011) · Communicative & Integrative Biology · doi:10.4161/cib.4.3.14766 · Cited by 33
The role of STEP in Alzheimer's disease
Kurup, P. K., Zhang, Y., Venkitaramani, D. V., Xu, J., & Lombroso, P. J. (2010) · Channels · doi:10.4161/chan.4.5.12910 · Cited by 29
Chen, Q., Li, Y., Zhong, L., Zhao, Q., & Fan, L. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9536-1 · Cited by 28
Francis, D. M., Kumar, G. S., Koveal, D., Tortajada, A., Page, R., & Peti, W. (2013) · Structure · doi:10.1016/j.str.2013.07.003 · Cited by 21
Walker, T. D., Mitchell, C., Park, M. A., Yacoub, A., Rahmani, M., Häussinger, D., Reinehr, R., Voelkel‐Johnson, C., Fisher, P. B., Grant, S., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1131 · Cited by 18
Modulation of STAT5 Interaction with LMW-PTP during Early Megakaryocyte Differentiation
Rigacci, S., Guidotti, V., Parri, M., & Berti, A. (2008) · Biochemistry · doi:10.1021/bi701131e · Cited by 17
Pei, Z., Chen, X., Sun, C., Du, H., Wei, H., Song, W., Yang, Y., Zhang, M., Lu, W., Cheng, R. Q., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12331 · Cited by 12
A summit for G7(tmR) G protein-coupled receptors
Sargiacomo, M., & Costa, T. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)80972-x · Cited by 2
Cited by
Targeted protein degradation by PROTACs
Neklesa, T. K., Winkler, J. D., & Crews, C. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.027 · Cited by 599
The cellular and molecular bases of leptin and ghrelin resistance in obesity
Cui, H., López, M., & Rahmouni, K. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.222 · Cited by 477
CD45 in human physiology and clinical medicine
Rheinländer, A., Schraven, B., & Bommhardt, U. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.009 · Cited by 294
Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation
Zhu, G., Xie, J., Kong, W., Xie, J., Li, Y., Du, L., Zheng, Q., Sun, L., Guan, M., Li, H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.002 · Cited by 267
Self-citationAntidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Nowell, J., Blunt, E., Gupta, D., & Edison, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101979 · Cited by 179
Metadata
- Authors
- He, R.-J., Yu, Z.-H., Zhang, R.-Y., & Zhang, Z.-Y.
- Venue
- Acta Pharmacologica Sinica
- Published
- 2014-09-15
- Volume
- 35
- Issue
- 10
- Pages
- 1227-1246
- ISSN
- 0253-9756 (ISSN-L)
- 1671-4083
- 1745-7254
- OpenAlex
- W2015964672
- Cited by
- 327
- References
- 253
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
